“Our government remains focused on empowering Canadians—by lowering costs, expanding opportunity, and protecting the vital social programs Canadians rely on, from child care to dental care to pharmacare.”

Those were the words of the federal government in the November 2025 budget.

Fast forward to spring 2026. 

From the Spring Economic Update, it appears that there will be no new federal funding for additional pharmacare deals. With the bilateral health funding dropping from $4.3 billion in 2025-26 to $3.1 billion in 2027-28, it seems that the federal government doesn’t see a future for national pharmacare.
Read more.